Insider · CIK 0001190644
Douglas S Ingram
directorceoofficer
Files at SRPT (Sarepta Therapeutics, Inc.), ARWR (ARROWHEAD PHARMACEUTICALS, INC.), RLAY (Relay Therapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | AGrant or award Common Stock | +7,819 | $0.00 | $0 | 46,215 | Dec 18, 2025 |
| Dec 7, 2025 | SRPT Sarepta Therapeutics, Inc. | AGrant or award Common Stock | +50,000 | $0.00 | $0 | 440,307 | Dec 9, 2025 |
| Dec 7, 2025 | SRPT Sarepta Therapeutics, Inc. | AGrant or award Common Stock | +50,000 | $0.00 | $0 | 490,307 | Dec 9, 2025 |
| Dec 7, 2025 | SRPT Sarepta Therapeutics, Inc. | AGrant or award Common Stock | +73,001 | $0.00 | $0 | 563,308 | Dec 9, 2025 |
| Dec 7, 2025 | SRPT Sarepta Therapeutics, Inc. | AGrant or award Common Stock | +96,541 | $0.00 | $0 | 659,849 | Dec 9, 2025 |
| Dec 7, 2025 | SRPT Sarepta Therapeutics, Inc. | AGrant or award Common Stock | +269,542 | $0.00 | $0 | 929,391 | Dec 9, 2025 |
| Jun 6, 2025 | RLAY Relay Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +136,681 | $0.00 | $0 | 136,681 | Jun 6, 2025 |
| Feb 6, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | AGrant or award Common Stock | +38,396 | $20.09 | $771k | 38,396 | Feb 7, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.